Published in Oncotarget on November 07, 2016
ras genes. Annu Rev Biochem (1987) 22.59
Rho GTPases: biochemistry and biology. Annu Rev Cell Dev Biol (2005) 16.77
MATCH: A tool for searching transcription factor binding sites in DNA sequences. Nucleic Acids Res (2003) 11.82
Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genes. Cell (1988) 10.29
EMT and dissemination precede pancreatic tumor formation. Cell (2012) 9.27
Pancreatic cancer. Annu Rev Pathol (2008) 6.96
An in vivo platform for translational drug development in pancreatic cancer. Clin Cancer Res (2006) 5.52
Altered growth of human colon cancer cell lines disrupted at activated Ki-ras. Science (1993) 4.76
A transposon-based genetic screen in mice identifies genes altered in colorectal cancer. Science (2009) 4.16
A tale of three fingers: the family of mammalian Sp/XKLF transcription factors. Nucleic Acids Res (1999) 3.68
A role for Rho in Ras transformation. Proc Natl Acad Sci U S A (1995) 3.59
KRAS codon 12 mutations occur very frequently in pancreatic adenocarcinomas. Nucleic Acids Res (1988) 3.31
Large-scale mutagenesis in p19(ARF)- and p53-deficient mice identifies cancer genes and their collaborative networks. Cell (2008) 3.25
Cross-talk between Ras and Rho signalling pathways in transformation favours proliferation and increased motility. EMBO J (2001) 2.66
Divergent roles for RalA and RalB in malignant growth of human pancreatic carcinoma cells. Curr Biol (2006) 2.61
Gene regulation by Sp1 and Sp3. Biochem Cell Biol (2004) 2.37
Repression of the miR-143/145 cluster by oncogenic Ras initiates a tumor-promoting feed-forward pathway. Genes Dev (2010) 2.37
Response markers and the molecular mechanisms of action of Gleevec in gastrointestinal stromal tumors. Mol Cancer Ther (2003) 2.27
Signal transduction and the Ets family of transcription factors. Oncogene (2000) 2.23
Cloning and characterization of GEF-H1, a microtubule-associated guanine nucleotide exchange factor for Rac and Rho GTPases. J Biol Chem (1998) 2.17
Cellular functions of GEF-H1, a microtubule-regulated Rho-GEF: is altered GEF-H1 activity a crucial determinant of disease pathogenesis? Trends Cell Biol (2008) 1.80
The Ras superfamily of GTPases. FASEB J (1996) 1.70
RREB-1, a novel zinc finger protein, is involved in the differentiation response to Ras in human medullary thyroid carcinomas. Mol Cell Biol (1996) 1.63
In vitro modeling of human pancreatic duct epithelial cell transformation defines gene expression changes induced by K-ras oncogenic activation in pancreatic carcinogenesis. Cancer Res (2005) 1.61
Expression cloning of lfc, a novel oncogene with structural similarities to guanine nucleotide exchange factors and to the regulatory region of protein kinase C. J Biol Chem (1995) 1.56
Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells. Cancer Res (2006) 1.32
Rho GTPases: potential candidates for anticancer therapy. Cancer Lett (2004) 1.23
The RhoA activator GEF-H1/Lfc is a transforming growth factor-beta target gene and effector that regulates alpha-smooth muscle actin expression and cell migration. Mol Biol Cell (2010) 1.18
Oncogenic Ras leads to Rho activation by activating the mitogen-activated protein kinase pathway and decreasing Rho-GTPase-activating protein activity. J Biol Chem (2002) 1.02
Overexpressed hPTTG1 promotes breast cancer cell invasion and metastasis by regulating GEF-H1/RhoA signalling. Oncogene (2011) 1.01
Sp1 transcription factor: A long-standing target in cancer chemotherapy. Pharmacol Ther (2015) 1.00
The RhoGEF GEF-H1 is required for oncogenic RAS signaling via KSR-1. Cancer Cell (2014) 0.99
ConTra v2: a tool to identify transcription factor binding sites across species, update 2011. Nucleic Acids Res (2011) 0.97
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells. Nucleic Acids Res (2014) 0.92
GEF-H1 over-expression in hepatocellular carcinoma promotes cell motility via activation of RhoA signalling. J Pathol (2012) 0.90
Activation of gef-h1, a guanine nucleotide exchange factor for RhoA, by DNA transfection. Int J Cancer (2005) 0.87
Evidence for changes in RREB-1, ZIP3, and Zinc in the early development of pancreatic adenocarcinoma. J Gastrointest Cancer (2012) 0.87
TGF-β regulates LARG and GEF-H1 during EMT to affect stiffening response to force and cell invasion. Mol Biol Cell (2014) 0.87
Mutant K-RAS Promotes Invasion and Metastasis in Pancreatic Cancer Through GTPase Signaling Pathways. Cancer Growth Metastasis (2015) 0.82
RalB regulates contractility-driven cancer dissemination upon TGFβ stimulation via the RhoGEF GEF-H1. Sci Rep (2015) 0.80
Transcriptional Regulation of miR-31 by Oncogenic KRAS Mediates Metastatic Phenotypes by Repressing RASA1. Mol Cancer Res (2016) 0.77